Management of Constitutional Delay
A 9-year-old boy is shorter than his classmates. He is well with no dysmorphic features. His height is on the 3rd percentile with a growth velocity of 5 cm per year. Bone age is 7 years, IGF-1 is low for chronological age but normal for bone age, and thyroid function and celiac serology are normal. His father grew substantially after leaving school. What is the most appropriate next step?
- A.Reassurance with growth monitoring and review in six monthsCorrect
- B.Start recombinant human growth hormone therapy
- C.Magnetic resonance imaging of the pituitary gland
- D.Growth hormone stimulation testing with clonidine
Explanation
This boy fits constitutional delay of growth and puberty, a normal variant in which reassurance and serial growth monitoring are the correct management. The two findings that make pathology unlikely are the preserved growth velocity of 5 cm per year, which is normal for a prepubertal school age child, and an IGF-1 that is appropriate once interpreted against bone age rather than chronological age. Documenting growth over another 6 to 12 months is both diagnostic and therapeutic, because continued normal velocity confirms the diagnosis, while a falling velocity or centile crossing would trigger formal endocrine testing. Growth hormone therapy is not indicated because there is no evidence of growth hormone deficiency, and giving it to a child with constitutional delay exposes him to daily injections and cost without altering his genetically determined adult height. Pituitary MRI is reserved for proven growth hormone deficiency or for red flags such as headache, visual field loss, diabetes insipidus, or a very low growth velocity. Growth hormone stimulation testing is appropriate when growth velocity is subnormal or IGF-1 is low for bone age, neither of which applies. Celiac disease and hypothyroidism have already been excluded by normal serology and thyroid function. For an older adolescent with marked psychosocial distress, a short course of low dose testosterone can be used to induce puberty and accelerate growth without compromising final height.
Why each option
- A.
- Correct. Normal growth velocity with an IGF-1 appropriate for bone age supports constitutional delay, for which observation and serial growth measurement are sufficient.
- B.
- Growth hormone is indicated for proven deficiency or specific syndromes and does not increase final height in constitutional delay.
- C.
- Pituitary MRI follows a confirmed diagnosis of growth hormone deficiency or the presence of neurologic red flags, none of which are present.
- D.
- Growth hormone stimulation testing is warranted when growth velocity is subnormal or IGF-1 is low for bone age, which is not the case here.
Reference: UpToDate 2025, Causes of short stature and approach to management
This is one of 3,306 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank